Danske Bank downgraded Zealand Pharma to Sell from Buy with a DKK 600 price target. The analyst sees an unfavorable risk/reward following the post-data share rally.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ZLDPF: